pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-605 |
Genomic Coordinates | chr10: 51299573 - 51299655 |
Synonyms | MIRN605, hsa-mir-605, MIR605 |
Description | Homo sapiens miR-605 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-605-5p | ||||||||||||||||||||||||||||||||||||
Sequence | 16| UAAAUCCCAUGGUGCCUUCUCCU |38 | ||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||
Experiments | SAGE | ||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MANBAL | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | mannosidase beta like | ||||||||||||||||||||
Transcript | NM_001003897 | ||||||||||||||||||||
Other Transcripts | NM_022077 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MANBAL | |||||||||||||||||||||
3'UTR of MANBAL (miRNA target sites are highlighted) |
>MANBAL|NM_001003897|3'UTR 1 AAGAGGAGGCCTGAGGAGCTGGGCGGGCAGGGAGAGGGTCTTGGGGACAGCCCTCCTGGGAATCTACATTGTGTTCCCCC 81 GCATTCCAGGCTCAGGGTCTGAGGAGGCTGTGACGCCCTATGACCGCAGAGATCTAGACAGTCGTAACAGTCCCCAGGCT 161 CCAGCTGGGCAATCCACCACTTCCTCTTCCTTCTGCTTCTGTGACGGTTTAGAGTCAAGGGGGCTGAAACACACTGTGAG 241 CATAGACTGTATTAGGTTTGTTCAGAAGCCGGGTCAGCTCACAGAGTCACATTTTCTTGCTTAGTCATGTGTCCCTCCTT 321 GAGTTGCCCCCTCCTTGTGGGTTTACACTACATTTGGGAGTCATTGTCTAATGCTGACAAGCACACCCTCTCCCATTATT 401 TGTGCACTACAGATCTCCTCCTGATCAGTCACCTTTGTTGCTGCTGTGTAGACAGAGCCAGGCCTCACCTGTTTGTTTAG 481 GCCAAGATGCCATGGACATGCAGCGTTAGTGATCCCACTAGCTGTGACAGCCAGGCCCAGAAAATGCCTGGCGTGAGAGC 561 CAGCAGACAGCCAGGCCAGGGTAGGCAGTGCCTGCTTCTGCTCCATCAGGTGCAGGGGATTTGGCTGAAGGCGTGCATAT 641 TTCCTGGGCACAAACTTCCTGAGCCTCTGAAATGGGAGGCTCGTCAATTTCAGACCAACCTCTTTTCAACCCATCATAGC 721 ACGTTCAAGGTGTGCCTTTTACTTCTACCTGTACATCCCCCATCCCTTCAATTCTTTCATTCCCTGACCAGTGAGAGGGT 801 TCCTGGGGGAAGTATGGTGAATAAACTGACATGCATGCTTCAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 881 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | LCL-BAC | ||||||
Disease | MIMAT0003273 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020023. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020023 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000373606.3 | 3UTR | UUGGCUGAAGGCGUGCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
107 hsa-miR-605-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001230 | SEC24D | SEC24 homolog D, COPII coat complex component | 3 | 1 | ||||||||
MIRT016155 | TP53 | tumor protein p53 | 2 | 1 | ||||||||
MIRT016156 | TCEAL1 | transcription elongation factor A like 1 | 1 | 1 | ||||||||
MIRT016157 | MDM2 | MDM2 proto-oncogene | 2 | 1 | ||||||||
MIRT040476 | YBX1 | Y-box binding protein 1 | 1 | 1 | ||||||||
MIRT040477 | TMEM64 | transmembrane protein 64 | 1 | 1 | ||||||||
MIRT040478 | KDM5C | lysine demethylase 5C | 1 | 1 | ||||||||
MIRT040479 | TRAF4 | TNF receptor associated factor 4 | 1 | 1 | ||||||||
MIRT040480 | DRG1 | developmentally regulated GTP binding protein 1 | 1 | 1 | ||||||||
MIRT040481 | BCL9 | B-cell CLL/lymphoma 9 | 1 | 1 | ||||||||
MIRT055125 | SCD | stearoyl-CoA desaturase | 2 | 2 | ||||||||
MIRT057521 | CEP55 | centrosomal protein 55 | 2 | 2 | ||||||||
MIRT081129 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT096817 | ZSWIM6 | zinc finger SWIM-type containing 6 | 2 | 4 | ||||||||
MIRT100961 | CENPQ | centromere protein Q | 2 | 4 | ||||||||
MIRT263338 | ANAPC16 | anaphase promoting complex subunit 16 | 2 | 2 | ||||||||
MIRT274710 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT311193 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT360127 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT438269 | PSMD10 | proteasome 26S subunit, non-ATPase 10 | 2 | 1 | ||||||||
MIRT442464 | SLC25A13 | solute carrier family 25 member 13 | 2 | 2 | ||||||||
MIRT446110 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT463119 | ZNF507 | zinc finger protein 507 | 2 | 2 | ||||||||
MIRT470566 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT475059 | IVNS1ABP | influenza virus NS1A binding protein | 2 | 6 | ||||||||
MIRT482538 | ACTB | actin beta | 2 | 4 | ||||||||
MIRT494136 | DCAF7 | DDB1 and CUL4 associated factor 7 | 2 | 6 | ||||||||
MIRT495209 | EDN3 | endothelin 3 | 2 | 2 | ||||||||
MIRT495235 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT496762 | MANBAL | mannosidase beta like | 2 | 2 | ||||||||
MIRT498885 | ZNF12 | zinc finger protein 12 | 2 | 10 | ||||||||
MIRT499280 | NBPF11 | NBPF member 11 | 2 | 2 | ||||||||
MIRT507063 | H3F3B | H3 histone family member 3B | 2 | 2 | ||||||||
MIRT508352 | HES7 | hes family bHLH transcription factor 7 | 2 | 8 | ||||||||
MIRT510740 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT519872 | ZFP62 | ZFP62 zinc finger protein | 2 | 4 | ||||||||
MIRT521272 | RTN4 | reticulon 4 | 2 | 4 | ||||||||
MIRT522324 | NFIB | nuclear factor I B | 2 | 6 | ||||||||
MIRT525011 | ACTN4 | actinin alpha 4 | 2 | 6 | ||||||||
MIRT526608 | AASDH | aminoadipate-semialdehyde dehydrogenase | 2 | 4 | ||||||||
MIRT529043 | ARL9 | ADP ribosylation factor like GTPase 9 | 2 | 2 | ||||||||
MIRT529545 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT532500 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT532599 | SIX4 | SIX homeobox 4 | 2 | 2 | ||||||||
MIRT534044 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT534087 | SPPL3 | signal peptide peptidase like 3 | 2 | 2 | ||||||||
MIRT534249 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT534286 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT534555 | RUNX1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT536765 | HOXB2 | homeobox B2 | 2 | 2 | ||||||||
MIRT537227 | GAN | gigaxonin | 2 | 2 | ||||||||
MIRT551105 | TTC8 | tetratricopeptide repeat domain 8 | 2 | 2 | ||||||||
MIRT552247 | DUSP3 | dual specificity phosphatase 3 | 2 | 2 | ||||||||
MIRT554361 | SFXN5 | sideroflexin 5 | 2 | 2 | ||||||||
MIRT557402 | H3F3C | H3 histone family member 3C | 2 | 2 | ||||||||
MIRT559116 | C16orf52 | chromosome 16 open reading frame 52 | 2 | 2 | ||||||||
MIRT560494 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT562296 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT562597 | CAPZA2 | capping actin protein of muscle Z-line alpha subunit 2 | 2 | 2 | ||||||||
MIRT563857 | ALYREF | Aly/REF export factor | 2 | 4 | ||||||||
MIRT565665 | SIX1 | SIX homeobox 1 | 2 | 2 | ||||||||
MIRT568253 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT609593 | GPM6B | glycoprotein M6B | 2 | 2 | ||||||||
MIRT611552 | GGT6 | gamma-glutamyltransferase 6 | 2 | 2 | ||||||||
MIRT613451 | CYLD | CYLD lysine 63 deubiquitinase | 2 | 2 | ||||||||
MIRT615516 | PRRC2A | proline rich coiled-coil 2A | 2 | 2 | ||||||||
MIRT617766 | C17orf105 | chromosome 17 open reading frame 105 | 2 | 2 | ||||||||
MIRT619134 | MCOLN3 | mucolipin 3 | 2 | 2 | ||||||||
MIRT621365 | CAP2 | cyclase associated actin cytoskeleton regulatory protein 2 | 2 | 2 | ||||||||
MIRT625804 | MDC1 | mediator of DNA damage checkpoint 1 | 2 | 2 | ||||||||
MIRT626954 | PRDM2 | PR/SET domain 2 | 2 | 2 | ||||||||
MIRT627716 | RCAN1 | regulator of calcineurin 1 | 2 | 2 | ||||||||
MIRT628069 | KCNJ13 | potassium voltage-gated channel subfamily J member 13 | 2 | 2 | ||||||||
MIRT630451 | GTPBP8 | GTP binding protein 8 (putative) | 2 | 2 | ||||||||
MIRT635533 | ELMOD2 | ELMO domain containing 2 | 2 | 2 | ||||||||
MIRT636206 | SULF2 | sulfatase 2 | 2 | 2 | ||||||||
MIRT638763 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT640324 | STAT1 | signal transducer and activator of transcription 1 | 2 | 2 | ||||||||
MIRT644548 | SPOP | speckle type BTB/POZ protein | 2 | 2 | ||||||||
MIRT645114 | TMX2 | thioredoxin related transmembrane protein 2 | 2 | 2 | ||||||||
MIRT647778 | NANOS1 | nanos C2HC-type zinc finger 1 | 2 | 2 | ||||||||
MIRT650112 | ZCCHC9 | zinc finger CCHC-type containing 9 | 2 | 2 | ||||||||
MIRT650136 | ABCB7 | ATP binding cassette subfamily B member 7 | 2 | 2 | ||||||||
MIRT650310 | SLC35E2 | solute carrier family 35 member E2 | 2 | 2 | ||||||||
MIRT650930 | ST6GALNAC1 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT651018 | ZNF740 | zinc finger protein 740 | 2 | 2 | ||||||||
MIRT653541 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT655752 | NR2C2 | nuclear receptor subfamily 2 group C member 2 | 2 | 2 | ||||||||
MIRT656908 | KIAA1958 | KIAA1958 | 2 | 2 | ||||||||
MIRT657854 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT658215 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT659884 | CAPN7 | calpain 7 | 2 | 2 | ||||||||
MIRT659922 | CACNA1E | calcium voltage-gated channel subunit alpha1 E | 2 | 2 | ||||||||
MIRT660055 | C12orf5 | TP53 induced glycolysis regulatory phosphatase | 1 | 1 | ||||||||
MIRT664616 | LIMD1 | LIM domains containing 1 | 2 | 2 | ||||||||
MIRT665392 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT667887 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT669018 | CHORDC1 | cysteine and histidine rich domain containing 1 | 2 | 2 | ||||||||
MIRT688419 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT691888 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT709530 | GEN1 | GEN1, Holliday junction 5' flap endonuclease | 2 | 2 | ||||||||
MIRT711013 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 2 | ||||||||
MIRT714731 | CENPH | centromere protein H | 2 | 2 | ||||||||
MIRT719897 | PTGIS | prostaglandin I2 synthase | 2 | 2 | ||||||||
MIRT725028 | CX3CL1 | C-X3-C motif chemokine ligand 1 | 2 | 2 | ||||||||
MIRT734348 | P2RY12 | purinergic receptor P2Y12 | 3 | 0 | ||||||||
MIRT736719 | TNFAIP3 | TNF alpha induced protein 3 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|